Unknown

Dataset Information

0

Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.


ABSTRACT: Multiple cytokines and inflammatory markers control TB infection. We aimed to investigate the changes in multiple cytokines and inflammatory markers in active TB patients following anti-TB drug therapy. Twenty-nine patients with active TB were recruited prospectively between December 2010 and July 2017. Blood samples were collected before (T0), after 2 months (T2), and at the end of anti-TB treatment (Tend). We measured the levels of Interferon (IFN)-?, interleukin (IL)-2, IL-12, IL-10, IL-13 and tumor necrosis factor (TNF)-? in supernatants collected from the QuantiFERON-TB Gold In-Tube assay (QFT-GIT), as well as the WBC, neutrophil, platelet count and neutrophil to lymphocyte ratio (NLR) in whole blood. Compared with baseline levels, WBC, neutrophil, and platelet counts were significantly lower following treatment. In addition, the NLR after treatment significantly decreased compared with baseline, whereas the IL-2/IFN-? ratio increased after treatment. In conclusion, the levels of IL-2/IFN-? ratios in the supernatant and the NLR might be useful biomarkers to evaluate the effectiveness of drug therapy in active TB patients.

SUBMITTER: Leem AY 

PROVIDER: S-EPMC5773481 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.

Leem Ah Young AY   Song Joo Han JH   Lee Eun Hye EH   Lee Hyejon H   Sim Bora B   Kim Song Yee SY   Chung Kyung Soo KS   Kim Eun Young EY   Jung Ji Ye JY   Park Moo Suk MS   Kim Young Sam YS   Chang Joon J   Kang Young Ae YA  

Scientific reports 20180118 1


Multiple cytokines and inflammatory markers control TB infection. We aimed to investigate the changes in multiple cytokines and inflammatory markers in active TB patients following anti-TB drug therapy. Twenty-nine patients with active TB were recruited prospectively between December 2010 and July 2017. Blood samples were collected before (T<sub>0</sub>), after 2 months (T<sub>2</sub>), and at the end of anti-TB treatment (T<sub>end</sub>). We measured the levels of Interferon (IFN)-γ, interleuk  ...[more]

Similar Datasets

| S-EPMC1176459 | biostudies-literature
| S-EPMC2702506 | biostudies-literature
| S-EPMC6838824 | biostudies-literature
| S-EPMC5758221 | biostudies-literature
| S-EPMC2478708 | biostudies-literature
| S-EPMC5384086 | biostudies-literature
| S-EPMC9246674 | biostudies-literature
| S-EPMC6492251 | biostudies-literature
| S-EPMC3889621 | biostudies-literature
| S-EPMC440606 | biostudies-literature